The iHope™ Genetic Health (iGH) program launched by Genetic Alliance and supported by Illumina aims to expand access to whole-genome sequencing to low- and middle-income communities around the world, with more than one-third of funds being allocated to patients in Africa. iGH is requesting information from stakeholders to formulate a Request for Proposals (RFP) from laboratories and their associated clinical sites to serve the needs of undiagnosed patients. They request information from all stakeholders, especially:
- Patients and families
- Genomic laboratories
- Hospitals and/or clinics that care for patients with genetic disorders
…but also from: Advocacy organizations, individual clinicians, healthcare administrators, genetic disease researchers, governmental agencies, and policy makers.
The deadline for responses is April 1st.
For more information: https://ihopegenetichealth.org/rfi